Diabetes Clinical Decision Support
Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals
Milton S. Hershey Medical Center
15,732 participants
Jul 15, 2022
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to determine the impact of an electronic medical record clinical decision support tool on rates of dysglycemia in the hospital, and its clinical and economical outcomes. The study also evaluates the perspectives of providers regarding the tool's usefulness on disease management support, knowledge, and practice performance.
Eligibility
Inclusion Criteria3
- Hospitalized adult (>18 years) patients at Penn State Health, Hershey Medical Center, St. Joseph's Hospital, Hampden Medical Center, and Holy Spirit Medical Center
- Ambulatory adult (>18 years) patients at Penn State Health, Hershey Medical Center
- Trigger of an alert or a disease management message
Exclusion Criteria1
- Children (<18 years)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This prospective intervention will be carried out over 36 months and encompass 12 alternating GlucAlert-CDS phases lasting 3 months each. Six active phases (ON period) and six inactive phases (OFF period) will represent 18 months of intervention and control respectively. GlucAlert-CDS recognizes gaps in care denoting the automatic process of subjects' identification and inclusion. During the ON period, gap in care events detected in patients' EMR will evoke alert messages and care recommendations for clinicians in real time for their consideration. These notifications are programmed to be delivered to primary inpatient providers in direct care of these hospitalized patients. During the OFF period, the program will record the gaps in care events detected, but alerts will be inactive for providers' viewing.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05447806